James Peyer (@jamespeyer) 's Twitter Profile
James Peyer

@jamespeyer

CEO @cambrianbio | PhD | creating medicines to keep people healthy | opinions my own

ID: 2542778971

linkhttp://cambrianbio.com calendar_today03-06-2014 04:33:03

907 Tweet

3,3K Followers

287 Following

Fareed Zakaria (@fareedzakaria) 's Twitter Profile Photo

People are living much longer. As that trend continues, how will our lives, society, and economy change? My conversation with Andrew J Scott about his new book, “The Longevity Imperative”:

Raghav "RV" Sehgal (@rv_sehgal) 's Twitter Profile Photo

⏰ Epigenetic clocks make a splash on the season finale of The Kardashians! 🤯 Exciting to witness Kim Kardashian, Khloé and Kris Jenner using TruDiagnostic's test to measure their biological age. It's a milestone as epigenetic aging biomarkers gain mainstream

⏰ Epigenetic clocks make a splash on the season finale of <a href="/kardashianshulu/">The Kardashians</a>! 🤯 

Exciting to witness <a href="/KimKardashian/">Kim Kardashian</a>, <a href="/khloekardashian/">Khloé</a> and <a href="/KrisJenner/">Kris Jenner</a>  using <a href="/TruDiagnostic/">TruDiagnostic</a>'s test to measure their biological age. It's a milestone as epigenetic aging biomarkers gain mainstream
Mark Cuban (@mcuban) 's Twitter Profile Photo

Aaron Levie Elon Musk Part of the misunderstanding of drug pricing is the impact of pharmacy benefit managers. Prior to Mark Cuban Cost Plus Drug Company publishing our price list, there was not a benchmark to compare prices. They made sure that every contract was opaque and under an NDA For instance, Box, Tesla,

Massimo (@rainmaker1973) 's Twitter Profile Photo

This monument in Novosibirsk, southwestern Siberia, honors the humble lab mouse and the important role mice have played in science. Unveiled in 2013, the quirky statue depicts an anthropomorphic mouse as an elderly woman, complete with glasses balanced atop its nose. Emerging

This monument in Novosibirsk, southwestern Siberia, honors the humble lab mouse and the important role mice have played in science.

Unveiled in 2013, the quirky statue depicts an anthropomorphic mouse as an elderly woman, complete with glasses balanced atop its nose. Emerging
James Peyer (@jamespeyer) 's Twitter Profile Photo

12pm ET today for members of the Longevity Biotechnology Association - chatting with Jamie Justice of XPRIZE "Everything you wanted to know about The X Prize" Stop into the virtual roundtable if you're a member. These have been a great series of small meetings for the community.

James Peyer (@jamespeyer) 's Twitter Profile Photo

A provocative and clever question. The door that opens once we have the first Phase 3 clinical data with a drug showing multi-disease prevention by an average of 36 months would be massive. Would create a race for innovation in the field.

James Peyer (@jamespeyer) 's Twitter Profile Photo

GLPs opening the door for interventions that really work to prevent major age-related diseases may end being one of the most important shift in healthcare this century. The Lasker is well deserved.

James Peyer (@jamespeyer) 's Twitter Profile Photo

Congratulations Kristen Fortney and team BioAge! Kristen & her team have successfully navigated a tough time in biotech. We're really looking forward to the readout of the azelaprag + GLP trials. Healthy treatment of obesity is the lowest hanging fruit of preventative medicine

Kristen Fortney (@kpfortney) 's Twitter Profile Photo

BioAge is now a public company! I'm incredibly proud of our team and grateful to our partners and investors who made this possible. By targeting the biology of aging, we're developing therapies to tackle metabolic diseases and change lives. Excited for what's ahead!

Loyal (@loyalfordogs) 's Twitter Profile Photo

Mark your calendars! Our Founder and CEO Celine Halioua is joining James Peyer and Alex Janin on stage at the The Wall Street Journal's Future of Everything next Wednesday, May 28 for a wide-ranging conversation about longevity drug development and the future of preventive medicine.

Mark your calendars! Our Founder and CEO <a href="/celinehalioua/">Celine Halioua</a> is joining <a href="/JamesPeyer/">James Peyer</a> and <a href="/AlexLJanin/">Alex Janin</a>  on stage at the <a href="/WSJ/">The Wall Street Journal</a>'s Future of Everything next Wednesday, May 28 for a wide-ranging conversation about longevity drug development and the future of preventive medicine.